Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

Nuclera has extended its Series C funding to a total [...]

A new study from researchers in Japan has uncovered a [...]

Expanded partnership includes new clinical trial and third SAFEbody discovery [...]

Alys Pharmaceuticals has submitted a clinical trial application (CTA) in [...]

Commit Biologics has announced the formation of a Scientific Advisory [...]